Imunon, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Imunon, Inc. (IMNN) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $3.74 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-11
- Imunon, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $3740000.00, a 461728295.06% increase year-over-year.
- Imunon, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.81, a 5.81% decline year-over-year.
- Imunon, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.86, a 34.85% decline year-over-year.
- Imunon, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $1.32, a 68.27% decline year-over-year.
- Imunon, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2017 was $2.69, a 85.12% decline from fiscal 2016.
- Imunon, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2016 was $18.08, a 669.36% increase from fiscal 2015.
- Imunon, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2015 was $2.35, a 33.43% decline from fiscal 2014.
- Imunon, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2014 was $3.53, a 19.59% decline from fiscal 2013.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month as first filed | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month as first filed | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month as first filed | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.74 10-Q · filed 2026-08-11 | |||||||
| 2026-03-31 | $3740000.00 10-Q · filed 2026-05-12 | |||||||
| 2025-06-30 | $0.81 10-Q · filed 2025-08-05 | |||||||
| 2025-03-31 | $0.81 10-Q · filed 2025-05-12 | |||||||
| 2024-09-30 | $1.13 10-Q · filed 2024-11-07 | |||||||
| 2024-06-30 | $1.18 10-Q · filed 2024-08-14 | |||||||
| 2024-03-31 | $0.86 10-Q · filed 2024-05-13 | |||||||
| 2023-09-30 | $2.03 10-Q · filed 2024-11-07 | |||||||
| 2023-06-30 | $1.32 10-Q · filed 2024-08-14 | |||||||
| 2023-03-31 | $1.32 10-Q · filed 2024-05-13 | |||||||
| 2022-09-30 | $4.16 10-Q · filed 2023-11-14 | $2.23 10-Q · filed 2022-11-14 | ||||||
| 2022-06-30 | $4.16 10-Q · filed 2023-08-10 | $2.81 10-Q · filed 2022-08-15 | ||||||
| 2022-03-31 | $4.16 10-Q · filed 2023-05-11 | |||||||
| 2021-09-30 | $1.97 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | $1.98 10-Q · filed 2022-08-15 | |||||||
| 2021-03-31 | $2.03 10-Q · filed 2022-05-16 | $2.24 10-Q · filed 2021-05-14 | ||||||
| 2020-09-30 | $3.07 10-Q · filed 2021-11-15 | |||||||
| 2020-06-30 | $3.10 10-Q · filed 2021-08-12 | |||||||
| 2020-03-31 | $1.01 10-Q · filed 2021-05-14 | |||||||
| 2018-03-31 | $2.52 10-Q · filed 2018-05-11 | |||||||
| 2017-12-31 | $2.69 10-K · filed 2018-03-27 | |||||||
| 2017-09-30 | $2.69 10-Q · filed 2017-11-14 | |||||||
| 2017-06-30 | $2.69 10-Q · filed 2017-08-14 | |||||||
| 2016-12-31 | $18.08 10-K · filed 2018-03-27 | $1.29 10-K · filed 2017-03-24 | ||||||
| 2016-09-30 | $1.29 10-Q · filed 2016-11-10 | |||||||
| 2016-06-30 | $1.33 10-Q · filed 2016-08-15 | |||||||
| 2016-03-31 | $1.33 10-Q · filed 2016-05-16 | |||||||
| 2015-12-31 | $2.35 10-K · filed 2017-03-24 | |||||||
| 2015-09-30 | $2.44 10-Q · filed 2015-11-05 | |||||||
| 2015-06-30 | $2.44 10-Q · filed 2015-08-10 | |||||||
| 2015-03-31 | $2.45 10-Q · filed 2015-05-11 | |||||||
| 2014-12-31 | $3.53 10-K · filed 2016-03-30 | |||||||
| 2014-09-30 | $3.54 10-Q · filed 2014-11-10 | |||||||
| 2014-06-30 | $3.55 10-Q · filed 2014-08-07 | |||||||
| 2014-03-31 | $3.66 10-Q · filed 2014-05-08 | |||||||
| 2013-12-31 | $4.39 10-K · filed 2016-03-30 | |||||||
| 2013-09-30 | $4.41 10-Q · filed 2013-11-12 | |||||||
| 2013-06-30 | $0.98 10-Q · filed 2013-08-08 | |||||||
| 2013-03-31 | $1.30 10-Q · filed 2013-05-09 | |||||||
| 2012-12-31 | $10.08 10-K · filed 2015-03-12 | $2.24 10-K · filed 2013-03-18 | ||||||
| 2012-09-30 | $2.11 10-Q · filed 2012-11-09 | |||||||
| 2012-06-30 | $2.11 10-Q · filed 2012-08-14 | |||||||
| 2011-12-31 | $16.52 10-K · filed 2014-03-13 | $3.67 10-K · filed 2013-03-18 | ||||||
| 2010-12-31 | $3.04 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |